Literature DB >> 23301228

A case with coexistence of major and minor BCR/ABL fusion transcript at lymphoblastic crisis of chronic myelogenous leukemia in patients with major BCR/ABL positivity during chronic phase.

Sang Hyuk Park, Hyun-Sook Chi, Young-Uk Cho, Seongsoo Jang, Chan-Jeoung Park, Ho-Joon Im.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23301228      PMCID: PMC3535203          DOI: 10.3343/alm.2013.33.1.80

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN: 2234-3806            Impact factor:   3.464


× No keyword cloud information.
  5 in total

1.  Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia.

Authors:  M Griesshammer; B Heinze; M Bangerter; H Heimpel; T M Fliedner
Journal:  J Mol Med (Berl)       Date:  1997 Nov-Dec       Impact factor: 4.599

2.  Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation.

Authors:  Noriaki Kawano; Shinya Okuda; Shuro Yoshida; Hiroko Kugimiya; Masaki Ito; Nagako Horikawa; Nobuaki Chosa; Tomoko Hisakata; Tomoko Fukudome; Ryoko Sakurai; Kiyoshi Yamashita; Akira Ueda; Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2011-11-08       Impact factor: 2.490

3.  Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients.

Authors:  M Griesshammer; B Heinze; A Hellmann; C Popp; B Anger; G Heil; M Bangerter; H Heimpel
Journal:  Ann Hematol       Date:  1996-11       Impact factor: 3.673

4.  Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia.

Authors:  Seung Hwan Oh; Tae Sung Park; Hye Ran Kim; Ja Young Lee; Jae Hyun Kim; Jeong Hwan Shin; Jeong Nyeo Lee
Journal:  Leuk Res       Date:  2009-05-17       Impact factor: 3.156

5.  The dual expression of minor and major bcr/abl chimeric mRNA in blast crisis of chronic myelogenous leukemia.

Authors:  M Tanaka; Y Yamazaki; M Hattori; K Tsushita; M Utsumi; S Yoshida
Journal:  Leuk Res       Date:  1996-07       Impact factor: 3.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.